LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a

Dandan Li,Jingjie Wang,Meixin Zhang,Xinhui Hu,Jiajun She,Xuemei Qiu,Xudong Zhang,Li Xu,Ying Liu,Shanshan Qin

DOI: https://doi.org/10.1016/j.omtn.2019.11.003

2020-03-01

Abstract:<p>Long non-coding RNAs play critical roles in tumorigenesis and tumor progression. However, the biological function of most lncRNA remains unknown in human gastric cancer (GC). This study here aims to explore the unknown function of lncRNA MAGI2-AS3 in GC. Firstly, bioinformatics analysis showed that lncRNA MAGI2-AS3 was overexpressed in gastric cancer tissues. And the overexpression of MAGI2-AS3 has been shown to be associated with poor prognosis in all three independent GC cohorts (TCGA_STAD, GSE62254 and GSE15459). The multivariate analysis indicated that lncRNA MAGI2-AS3 was an independent prognostic factor for both overall survival and disease-free survival of GC patients. Moreover, MAGI2-AS3 was identified to be an EMT related lncRNA and was highly co-expressed with ZEB1/2 in both GC tissues and normal stomach tissues. Loss-of-function and gain-of-function studies showed that lncRNA MAGI2-AS3 could positively regulate ZEB1 expression and the process of cell migration and invasion in GC. Subcellular location assay showed that lncRNA MAGI2-AS3 was mainly located in cytoplasm of GC cells. Bioinformatics analysis and functional experiments revealed that lncRNA MAGI2-AS3 was negatively correlated with miR-141/200a expression and negatively regulated miR-141/200a-3p expression in GC. Therefore, we speculate that lncRNA MAGI2-AS3 promotes tumor progression through sponging miR-141/200a and maintaining overexpression of ZEB1 in GC. Nevertheless, we identified BRD4 is a transcriptional regulator of lncRNA MAGI2-AS3 in GC. Additionally, our findings highlight that lncRNA MAGI2-AS3 is an ideal biomarker and could be a potential therapeutic target for gastric cancer.</p>